UBS lowered the firm’s price target on Keurig Dr Pepper (KDP) to $35 from $40 and keeps a Buy rating on the shares. While the firm notes the “caffeine crash” following the JDE Peets (JDEPF) deal news, it says that its sum-of-the-parts analysis points to upside so it maintains a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Strategic Acquisition and Spin-Off: Keurig Dr Pepper’s Path to Market Expansion and Value Creation
- Closing Bell Movers: MongoDB jumps nearly 30% after beat and raise
- Unusually active option classes on open August 26th
- AMD upgraded, PDD downgraded: Wall Street’s top analyst calls
- Keurig Dr Pepper’s Strategic Reversal Sparks Debt Concerns and Market Uncertainty, Earning Hold Rating